Skip to main content
. 2016 Jun;2(2):146–157. doi: 10.18383/j.tom.2016.00157

Figure 5.

Figure 5.

Metabolic inhibition selectively eliminates MDA-MB-231 cancer cells. The graphs show mean values ± SEM (N = 7 per condition) of fold-change in cancer cell bioluminescence and drug selectivity in spheroids composed of MDA-MB-231 cancer cells and HS-5 or HS-27A stromal cells treated with 2-deoxy-glucose (A), dichloroacetate (B), oligomycin (C), rotenone (D), DHEA (E), or PD0325901 (F).